
Jeffrey Kahn
· Andreas C. Dracopoulos Director; Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public PolicyJohns Hopkins University · Ophthalmology
Active 1949–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Jeffrey Kahn, PhD, MPH, is the Andreas C. Dracopoulos Director of the Johns Hopkins Berman Institute of Bioethics, a position he assumed in July 2016 and was re-appointed to for a second five-year term in 2023. He has been the Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy since 2011. He is also a Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. His work spans a variety of areas in bioethics, exploring the intersection of ethics and health/science policy, including human and animal research ethics, public health, and ethical issues in emerging biomedical technologies. Kahn has served on numerous advisory panels at the state and federal levels, including chairing the National Academies of Sciences, Engineering, and Medicine’s Board on Health Sciences Policy and committees on the use of chimpanzees in research, ethics principles for spaceflights, and mitochondrial replacement techniques. He is an elected member of the National Academy of Medicine and a Fellow of The Hastings Center. His research interests include the ethics of health and science policy, research ethics, public health, and emerging biomedical technologies. Kahn has published extensively, authored over 125 scholarly articles, and is a recognized speaker on bioethics topics worldwide.
Research topics
- Computer Science
- Medicine
- Biology
- Political Science
- Programming language
- Public relations
- Engineering ethics
- Dermatology
- Business
- Cell biology
Selected publications
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update
Stem Cell Reports · 2021 · 343 citations
The International Society for Stem Cell Research has updated its Guidelines for Stem Cell Research and Clinical Translation in order to address advances in stem cell science and other relevant fields, together with the associated ethical, social, and policy issues that have arisen since the last update in 2016. While growing to encompass the evolving science, clinical applications of stem cells, and the increasingly complex implications of stem cell research for society, the basic principles und…
Digital Contact Tracing for Pandemic Response
Johns Hopkins University Press eBooks · 2020 · 60 citations
1st authorCorrespondingDigital technologies are being developed and promoted to support the public health response to the COVID-19 pandemic, with discussion and implementation planning in the United States by localities, states, institutions, and employers. Key decision makers and stakeholders-including government officials, institutional leaders, employers, digital technology developers, and the public-require clear and well-supported guidance to inform the deployment and use of these technologies as well as of the d…
For now, it’s unethical to use human challenge studies for SARS-CoV-2 vaccine development
Proceedings of the National Academy of Sciences · 2020 · 54 citations
1st authorCorrespondingEmotions coordinate our behavior and physiological states during survival-salient events and pleasurable interactions. Even though we are often consciously aware of our current emotional state, such as anger or happiness, the mechanisms giving ...Emotions are often felt in the body, and somatosensory feedback has been proposed to trigger conscious emotional experiences. Here we reveal maps of bodily sensations associated with different emotions using a unique topographical self-report method. In…
Operational Recommendations for Scarce Resource Allocation in a Public Health Crisis
CHEST Journal · 2020 · 51 citations
Governing with public engagement: an anticipatory approach to human genome editing
Science and Public Policy · 2024 · 9 citations
In response to calls for public engagement on human genome editing (HGE), which intensified after the 2018 He Jiankui scandal that resulted in the implantation of genetically modified embryos, we detail an anticipatory approach to the governance of HGE. By soliciting multidisciplinary experts' input on the drivers and uncertainties of HGE development, we developed a set of plausible future scenarios to ascertain publics values-specifically, their hopes and concerns regarding the novel technology…
Recent grants
NIH · $826k · 2016
NIH · $442k · 2004
Beyond Boundaries: ELSI and the Complex Relationships between Infectious and Genetic Diseases
NIH · $4.8M · 2016–2022
Frequent coauthors
- 150 shared
Jeremy Sugarman
- 101 shared
Dennis L. Confer
National Marrow Donor Program
- 100 shared
Jeffrey McCullough
- 100 shared
Paolo Anderlini
- 100 shared
David Stroncek
National Institutes of Health
- 100 shared
Ellen Lazarus
Center for Biologics Evaluation and Research
- 100 shared
Derwood Pamphilon
- 100 shared
Mary Eapen
Awards & honors
- Elected Member of the National Academy of Medicine
- Fellow of The Hastings Center
- Founding President of the Association of Bioethics Program D…
Similar researchers at Johns Hopkins University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Jeffrey Kahn
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
